104 related articles for article (PubMed ID: 9591136)
21. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
[TBL] [Abstract][Full Text] [Related]
22. Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndrome.
Rouleau E; Lefol C; Bourdon V; Coulet F; Noguchi T; Soubrier F; Bièche I; Olschwang S; Sobol H; Lidereau R
Hum Mutat; 2009 Jun; 30(6):867-75. PubMed ID: 19224586
[TBL] [Abstract][Full Text] [Related]
23. Mutation detection by cycle sequencing.
Thierfelder L
Curr Protoc Hum Genet; 2001 May; Chapter 7():Unit 7.7. PubMed ID: 18428308
[TBL] [Abstract][Full Text] [Related]
24. Primer design for PCR and sequencing in high-throughput analysis of SNPs.
Vieux EF; Kwok PY; Miller RD
Biotechniques; 2002 Jun; Suppl():28-30, 32. PubMed ID: 12083394
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.
Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J
Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682
[TBL] [Abstract][Full Text] [Related]
26. [Molecular biology diagnosis of hereditary non-polyposis colorectal cancer (HNPCC)].
Roqué M; Pusiol E; Perinetti H; Mayorga L
Acta Gastroenterol Latinoam; 1999; 29(5):341-4. PubMed ID: 10668072
[No Abstract] [Full Text] [Related]
27. Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled amplicons.
Ricevuto E; Sobol H; Stoppa-Lyonnet D; Gulino A; Marchetti P; Ficorella C; Martinotti S; Meo T; Tosi M
Clin Cancer Res; 2001 Jun; 7(6):1638-46. PubMed ID: 11410501
[TBL] [Abstract][Full Text] [Related]
28. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
[TBL] [Abstract][Full Text] [Related]
29. Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue.
Bernstein JL; Thompson WD; Casey G; DiCioccio RA; Whittemore AS; Diep AT; Thakore SS; Vaziri S; Xue S; Haile RW
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):809-14. PubMed ID: 12223423
[TBL] [Abstract][Full Text] [Related]
30. Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family.
Miyaki M; Iijima T; Yamaguchi T; Shirahama S; Ito T; Yasuno M; Mori T
Mutat Res; 2004 Apr; 548(1-2):19-25. PubMed ID: 15063132
[TBL] [Abstract][Full Text] [Related]
31. Pitfalls and caveats in BRCA sequencing.
Bellosillo B; Tusquets I
Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125
[TBL] [Abstract][Full Text] [Related]
32. Adaptation of conformation-sensitive gel electrophoresis to an ALFexpress DNA sequencer to screen BRCA1 mutations.
Blesa JR; Hernández-Yago J
Biotechniques; 2000 May; 28(5):1019-25. PubMed ID: 10818710
[TBL] [Abstract][Full Text] [Related]
33. Detection of the most frequent mutations in BRCA1 gene on polyacrylamide gels containing Spreadex Polymer NAB.
Janatová M; Pohlreich P; Matous B
Neoplasma; 2003; 50(4):246-50. PubMed ID: 12937835
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of p53 in human tumors: direct DNA sequencing and SSCP.
Erster S; Slade N; Moll UM
Methods Mol Biol; 2003; 234():219-30. PubMed ID: 12824535
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the hMLH1 gene using an automated two-dimensional DNA typing system.
Sasaki S; Tokino T; Miyatsu T; Muto T; Nakamura Y
Hum Mutat; 1997; 9(2):164-71. PubMed ID: 9067757
[TBL] [Abstract][Full Text] [Related]
36. Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing.
Ang D; O'Gara R; Schilling A; Beadling C; Warrick A; Troxell ML; Corless CL
J Mol Diagn; 2013 May; 15(3):312-8. PubMed ID: 23541593
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Seo JH; Cho DY; Ahn SH; Yoon KS; Kang CS; Cho HM; Lee HS; Choe JJ; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Son GS; Lee JB; Koo BH
Hum Mutat; 2004 Oct; 24(4):350. PubMed ID: 15365993
[TBL] [Abstract][Full Text] [Related]
38. A new method for optimizing multiplex DNA microsatellite analysis in low quality archival specimens.
Drobinskaya I; Gabbert HE; Moeslein G; Mueller W
Anticancer Res; 2005; 25(5):3251-8. PubMed ID: 16101135
[TBL] [Abstract][Full Text] [Related]
39. Automated PCR detection of BRAF mutations in colorectal adenocarcinoma: a diagnostic test accuracy study.
Colling R; Wang LM; Soilleux E
J Clin Pathol; 2016 May; 69(5):398-402. PubMed ID: 26537294
[TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
